Microsoft Sentinel adds custom graphs to visualize security data and attack relationships. Graph-based analysis helps detect threats, map attack paths, and identify anomalies. Fabric-powered ...
A quick hands-on proof of concept shows how Visual Studio's new custom-agent framework can be aimed at a real Blazor project, along with what else is new in the March update.
Claude Mythos autonomously found zero-days in OpenBSD, FFmpeg, FreeBSD and major browsers that survived decades of expert ...
Gemini has got new powers to better visualize science concepts. The feature is rolling out to all users except those in ...
After shutting down in April 2025, DSC Labs has returned under new leadership. In July 2024, the company’s founders Susan and David Corley announced plans to close the company after 60 years in the ...
Microsoft has released version 1.0 of its open-source Agent Framework, positioning it as the production-ready evolution of the project introduced in October 2025 by combining Semantic Kernel ...
Want more charts like these? See our charts on the secrets of the jobless recovery, the richest 1 percent of Americans, and how the superwealthy beat the IRS. How Rich Are the Superrich? A huge share ...
Bill Phillips was an outsider to economics, but he used a machine and a chart to change the way we think about the government ...
Tazapay said Circle led a Series B extension that brought total funding to $36 million as the company expands cross-border payment rails. Bitcoin was down 44% from its $126,000 all-time highs as key ...
Understanding how much you earn and spend is the key to getting control of your finances. Creating a budget gives you a better sense of where your money is going and can help you achieve financial ...
IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions ...
About Arcturus Therapeutics Holdings Inc. Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious ...